Actuate Therapeutics, Inc. share price logo

Actuate Therapeutics, Inc.

NASDAQ: ACTU

$0.34

-0.04

(-9.68%)

as on

Actuate Therapeutics, Inc. Stock Performance

as on November 2, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $0.33
    $0.37
    downward going graph

    1.52%

    Downside

    10.41%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.33
    $7.90
    downward going graph

    1.52%

    Downside

    2257.51%

    Upside

    downward going graph

Actuate Therapeutics, Inc. share price movements today

Previous Close
$0.37
Open
$0.37
Volume
1.6M
Market Cap
$18.4M
Day's Low - High
$0.33 - $0.37
52 Week Low - High
$0.33 - $7.90

Actuate Therapeutics, Inc. Historical Returns

1 Month Return
-59.08 %
3 Month Return
-69.81 %
1 Year Return
-94.97 %
3 Year Return
0 %
5 Year Return
0 %

Actuate Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Actuate Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$18.4M

EPS (TTM)

-0.89

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.38

Industry PE ratio

-3.13

PEG Ratio

-0.00

EBITDA

-20.5M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-346.18%

Actuate Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Actuate Therapeutics, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$18.4MNA-0.380.00%0.00%
Neutral$88.5B-36.40%-27.78-12.57%0.00%
StrongBuy$141.7B208.09%32.2786.04%0.00%
Buy$95.5B45.26%19.7685.77%0.40%

Stock Returns calculator for Actuate Therapeutics, Inc. Stock including INR - Dollar returns

The Actuate Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Actuate Therapeutics, Inc. investment value today

Current value as on today

₹5,382

Returns

-₹94,618

(-94.62%)

Returns from Actuate Therapeutics, Inc. Stock

-₹94,968 (-94.97%)

Dollar Impact

₹350 (+0.35%)

Analyst Recommendation on Actuate Therapeutics, Inc. Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Actuate Therapeutics, Inc.. Average target price of $15

Actuate Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Actuate Therapeutics, Inc..

Current Price

$0.3351

Analyzed by

1 Analysts

High

$15

0

Low

$15

Actuate Therapeutics, Inc. target price $0, a slight upside of 0% compared to current price of $0.3351. According to 1 analysts rating.

Indian Investors' Interest in Actuate Therapeutics, Inc. Stock

Search interest for Actuate Therapeutics, Inc. Stock has increased by 176% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:176% versus previous 30 day period

Actuate Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-7
-5
-5
-6
-6
-5
-5
-4
-5
-4
EBITDA
-8
-6
-5
0
-6
-5
-5
-4
-5
-4
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
-
-
-
6
-
-
-
-
-
-
Income Before Tax
-8
-6
-5
-6
-6
-5
-5
-4
-5
-4
Income Tax Expense
-
-
-
-
-
-
-
0
-
-
Net Income
-8
-6
-5
-6
-6
-5
-5
-4
-5
-4
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Actuate Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Income
-20
-24
-25
-22
EBITDA
0
0
-2
-22
Interest Expense
0
0
0
0
Depreciation
20
24
25
-
Income Before Tax
-20
-24
-27
-22
Income Tax Expense
-
-
0
-
Net Income
-20
-24
-27
-22
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

Actuate Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-8
-6
-5
-6
-6
-5
-5
-4
-5
-4
Operating Cash Flow
-5
-2
-9
-4
-4
-4
-6
-3
-5
-4
Investing Cash Flow
-
-
-
-
-
-
-
-
-
-
Financing Cash Flow
4
0
22
0
0
6
17
0
0
0
Change in Cash
0
-1
13
-4
-4
2
10
-3
-5
-3

Actuate Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-20
-24
-27
-22
Operating Cash Flow
-17
-21
-21
-19
Investing Cash Flow
-
-
-
-
Financing Cash Flow
19
4
27
23
Change in Cash
1
-17
5
4

Global Institutional Holdings in Actuate Therapeutics, Inc.

Check out the Institutions with significant holdings in Actuate Therapeutics, Inc..

Funds
Holdings
Aaron G.L. Fletcher
42.46%
Todd Thomson
9.80%
DANIEL M SCHMITT
4.47%
VANGUARD INDEX FUNDS
1.64%
Vanguard
1.64%

Actuate Therapeutics, Inc. News & Key Events

  • img

    Today's Timeline - 27 October

    Tue, 05:30 PM

    -

    Actuate Therapeutics announces $11M public offering of shares and warrants, expected to close on October 28.

Insights on Actuate Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 716.3% return, outperforming this stock by 811.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, ACTU stock has moved down by -36.5%

About Actuate Therapeutics, Inc.

Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers. Its primary drug candidate is Elraglusib Injection, an innovative glycogen synthase kinase-3 (GSK-3) inhibitor designed to combat metastatic pancreatic ductal adenocarcinoma. Furthermore, Elraglusib is being developed to address other malignancies, including Ewing sarcoma, metastatic melanoma, and colorectal cancer. Originally named Apotheca Therapeutics, Inc., the organization rebranded as Actuate Therapeutics, Inc. in October 2015. Established in 2015, the company maintains its headquarters in Fort Worth, Texas.
OrganisationActuate Therapeutics, Inc.
Headquarters1751 River Run, Fort Worth, TX, 76107, US
IndustryBiotechnology
CEODaniel Schmitt

Key Management of Actuate Therapeutics, Inc.

Name

Title

Mr. Paul J. Lytle CPA

Chief Financial Officer

Dr. Alan Kozikowski Ph.D.

Scientific Founder and Advisor

Dr. Andrew P. Mazar Ph.D.

Co-Founder & COO

FAQs

What is Actuate Therapeutics, Inc. share price today?

Actuate Therapeutics, Inc. share price today is $0.34 as on at the close of the market. Actuate Therapeutics, Inc. share today touched a day high of $0.37 and a low of $0.33.

What is the 52 week high and 52 week low for Actuate Therapeutics, Inc. share?

Actuate Therapeutics, Inc. share touched a 52 week high of $7.90 on and a 52 week low of $0.33 on . Actuate Therapeutics, Inc. stock price today i.e. is closed at $0.34,which is 95.76% down from its 52 week high and 1.55% up from its 52 week low.

What is Actuate Therapeutics, Inc.'s market capitalisation today?

Actuate Therapeutics, Inc. market capitalisation is $0.00T as on .

How to invest in Actuate Therapeutics, Inc. Stock (ACTU) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Actuate Therapeutics, Inc. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Actuate Therapeutics, Inc. Stock (ACTU) from India?

Indian investors can start investing in Actuate Therapeutics, Inc. (ACTU) shares with as little as ₹94.9000015258789 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.00 in Actuate Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Actuate Therapeutics, Inc. share’s latest price of $0.34 as on November 2, 2026 at 8:46 am IST, you will get 29.8418 shares of Actuate Therapeutics, Inc.. Learn more about fractional shares .